» Articles » PMID: 39747518

Bayesian Analysis of the Rate of Spontaneous Malignant Mesothelioma Among BAP1 Mutant Mice in the Absence of Asbestos Exposure

Overview
Journal Sci Rep
Specialty Science
Date 2025 Jan 2
PMID 39747518
Authors
Affiliations
Soon will be listed here.
Abstract

Cancers of the mesothelium, such as malignant mesothelioma (MM), historically have been attributed solely to exposure to asbestos. Recent large scale genetic and genomic functional studies now show that approximately 20% of all human mesotheliomas are causally linked to highly penetrant inherited (germline) pathogenic mutations in numerous cancer related genes. The rarity of these mutations in humans makes it difficult to perform statistically conclusive genetic studies to understand their biological effects. This has created a disconnect between functional and epidemiological studies. However, since the molecular pathogenesis of MM in mice accurately recapitulates that of human disease, this disconnect between functional and epidemiological studies can be overcome by using inbred mouse strains that harbor mutation(s) in genes involved in the disease. Most mouse studies have focused on the effect of asbestos exposure, leaving the effects of genetic mutations in the absence of exposure understudied. Here, using existing peer-reviewed studies, we investigate the rate of spontaneous MM among mice with and without germline genetic mutations, in the absence of asbestos exposure. We leveraged these published data to generate a historical control dataset (HCD) to allow us to improve statistical power and account for genetic heterogeneity between studies. Our Bayesian analyses indicate that the odds of spontaneous MM among germline BAP1 mutant mice is substantially larger than that of wildtype mice. These results support the existing biological study findings that mesotheliomas can arise in the presence of pathogenic germline mutations, independently of asbestos exposure.

References
1.
Huang P, Duda D, Jain R, Fukumura D . Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice. Comp Med. 2008; 58(3):253-63. PMC: 2693079. View

2.
Congedo M, West E, Evangelista J, Mattingly A, Calabrese G, Sassorossi C . The genetic susceptibility in the development of malignant pleural mesothelioma: somatic and germline variants, clinicopathological features and implication in practical medical/surgical care: a narrative review. J Thorac Dis. 2024; 16(1):671-687. PMC: 10894363. DOI: 10.21037/jtd-23-611. View

3.
Testa J, Cheung M, Pei J, Below J, Tan Y, Sementino E . Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011; 43(10):1022-5. PMC: 3184199. DOI: 10.1038/ng.912. View

4.
Waters A, Brendler-Spaeth T, Smith D, Offord V, Tan H, Zhao Y . Saturation genome editing of BAP1 functionally classifies somatic and germline variants. Nat Genet. 2024; 56(7):1434-1445. PMC: 11250367. DOI: 10.1038/s41588-024-01799-3. View

5.
Bertelsen B, Tuxen I, Yde C, Gabrielaite M, Torp M, Kinalis S . High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer. NPJ Genom Med. 2019; 4:13. PMC: 6588611. DOI: 10.1038/s41525-019-0087-6. View